The utilization and challenges of Japan's MID-NET ® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies.

MLA

Yamada, Kaori, et al. “The Utilization and Challenges of Japan’s MID-NET ® Medical Information Database Network in Postmarketing Drug Safety Assessments: A Summary of Pilot Pharmacoepidemiological Studies.” Pharmacoepidemiology and Drug Safety, vol. 28, no. 5, May 2019, pp. 601–08. EBSCOhost, https://doi.org/10.1002/pds.4777.

APA

Yamada, K., Itoh, M., Fujimura, Y., Kimura, M., Murata, K., Nakashima, N., Nakayama, M., Ohe, K., Orii, T., Sueoka, E., Suzuki, T., Yokoi, H., Ishiguro, C., & Uyama, Y. (2019). The utilization and challenges of Japan’s MID-NET ® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies. Pharmacoepidemiology and Drug Safety, 28(5), 601–608. https://doi.org/10.1002/pds.4777

Chicago

Yamada, Kaori, Maori Itoh, Yoshiaki Fujimura, Michio Kimura, Koichiro Murata, Naoki Nakashima, Masaharu Nakayama, et al. 2019. “The Utilization and Challenges of Japan’s MID-NET ® Medical Information Database Network in Postmarketing Drug Safety Assessments: A Summary of Pilot Pharmacoepidemiological Studies.” Pharmacoepidemiology and Drug Safety 28 (5): 601–8. doi:10.1002/pds.4777.